Bristol-Myers Squibb Co. (NYSE: BMY) Has Slid Negatively For The Year To Date, Predicting What Will Happen Next

Bristol-Myers Squibb Co. (NYSE:BMY)’s traded shares stood at 10.91 million during the last session, with the company’s beta value hitting 0.42. At the close of trading, the stock’s price was $48.30, to imply an increase of 0.96% or $0.46 in intraday trading. The BMY share’s 52-week high remains $70.93, putting it -46.85% down since that peak but still an impressive 1.49% since price per share fell to its 52-week low of $47.58. The company has a valuation of $97.89B, with an average of 15.90 million shares over the past 3 months.

Bristol-Myers Squibb Co. (NYSE:BMY) trade information

After registering a 0.96% upside in the last session, Bristol-Myers Squibb Co. (BMY) has traded red over the past five days. The stock hit a weekly high of 49.10, jumping 0.96% in its intraday price action. The 5-day price performance for the stock is -1.67%, and -6.76% over 30 days. With these gigs, the year-to-date price performance is -5.87%.

Bristol-Myers Squibb Co. (BMY) estimates and forecasts

Looking at statistics comparing Bristol-Myers Squibb Co. share performance against respective industry, we note that the company has underperformed competitors. Bristol-Myers Squibb Co. (BMY) shares are -15.81% down over the last 6 months, with its year-to-date growth rate lower than industry average at -91.21% against 13.10%.

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 5.14% for the past 5-year period. While 2024 is set for a -91.38% return in earnings, projections for the next 5 years are at -4.17% annually.

BMY Dividends

Bristol-Myers Squibb Co. has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Bristol-Myers Squibb Co. has a forward dividend ratio of 2.34, with the share yield ticking at 4.84% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.